Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of DRV/r dose simplification in virologically suppressed HAART-experienced HIV-positive patients
2009-016705-42Phase 4Terminated
- Sponsor
- National Institute for Infectious Diseases Lazzaro Spallanzani
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of darunavir in human immunodeficiency virus infection (HIV), sponsored by National Institute for Infectious Diseases Lazzaro Spallanzani. Primary endpoint: Virological suppression at Week 48. Started Nov 2009; status: terminated.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-016705-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016705-42.